A review of tickets determined that there are no other complaints for lot 11020lp41 and there were no trends identified for the product for the issue.Return testing was not completed as returns were not available.Accuracy testing was performed with a retained kit of lot 11020lp41 and an internal insulin panel.All acceptance criteria were met, which indicates acceptable product performance.A review of the manufacturing documentation did not identify any issues associated with the customer's observation.A review of the product labeling concluded that the issue is sufficiently addressed.Based on our investigation no product deficiency was identified for the architect insulin reagent, lot 11020lp41.
|